BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30015974)

  • 1. Knockdown of NUPR1 inhibits the growth of U266 and RPMI8226 multiple myeloma cell lines via activating PTEN and caspase activation‑dependent apoptosis.
    Zeng C; Li X; Li A; Yi B; Peng X; Huang X; Chen J
    Oncol Rep; 2018 Sep; 40(3):1487-1494. PubMed ID: 30015974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Knockdown of nuclear protein 1 (NUPR1) gene inhibits proliferation and promotes apoptosis of human multiple myeloma U266 cells].
    Zeng C; Yi B; Li X; Chen J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Sep; 33(9):1240-1246. PubMed ID: 29089084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUPR1 Silencing Induces Autophagy-Mediated Apoptosis in Multiple Myeloma Cells Through the PI3K/AKT/mTOR Pathway.
    Li A; Li X; Chen X; Zeng C; Wang Z; Li Z; Chen J
    DNA Cell Biol; 2020 Mar; 39(3):368-378. PubMed ID: 31971825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of NUPR1 inhibits the proliferation of glioblastoma cells via ERK1/2, p38 MAPK and caspase-3.
    Li J; Ren S; Liu Y; Lian Z; Dong B; Yao Y; Xu Y
    J Neurooncol; 2017 Mar; 132(1):15-26. PubMed ID: 28000106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentivirus-mediated RNAi knockdown of NUPR1 inhibits human nonsmall cell lung cancer growth in vitro and in vivo.
    Guo X; Wang W; Hu J; Feng K; Pan Y; Zhang L; Feng Y
    Anat Rec (Hoboken); 2012 Dec; 295(12):2114-21. PubMed ID: 22961798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway.
    He W; Cheng F; Zheng B; Wang J; Zhao G; Yao Z; Zhang T
    Aging (Albany NY); 2021 May; 13(10):14015-14038. PubMed ID: 34030133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trifluoperazine induces cellular apoptosis by inhibiting autophagy and targeting NUPR1 in multiple myeloma.
    Li A; Chen X; Jing Z; Chen J
    FEBS Open Bio; 2020 Oct; 10(10):2097-2106. PubMed ID: 32810364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling, and promotes cell apoptosis and cell cycle arrest in multiple myeloma.
    Ding T; Hao J
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-637 promotes apoptosis and suppresses proliferation and autophagy in multiple myeloma cell lines via NUPR1.
    Chen X; Li A; Zhan Q; Jing Z; Chen Y; Chen J
    FEBS Open Bio; 2021 Feb; 11(2):519-528. PubMed ID: 33332746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 Regulated Inhibitor of Apoptosis 1 (TRIAP1) stable silencing increases late apoptosis by upregulation of caspase 9 and APAF1 in RPMI8226 multiple myeloma cell line.
    Fook-Alves VL; de Oliveira MB; Zanatta DB; Strauss BE; Colleoni GW
    Biochim Biophys Acta; 2016 Jun; 1862(6):1105-10. PubMed ID: 27032384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Ras Homolog C/Rho-Associated Coiled-Protein Kinase (Rho/ROCK) Signaling Pathways on Proliferation and Apoptosis of Human Myeloma Cells.
    Feng X; Zhang L; Nie S; Zhuang L; Wang W; Huang J; Yan X; Meng F
    Med Sci Monit; 2019 Oct; 25():7605-7616. PubMed ID: 31599230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance.
    Emma MR; Iovanna JL; Bachvarov D; Puleio R; Loria GR; Augello G; Candido S; Libra M; Gulino A; Cancila V; McCubrey JA; Montalto G; Cervello M
    Cell Death Dis; 2016 Jun; 7(6):e2269. PubMed ID: 27336713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nupr1 regulates palmitate-induced apoptosis in human articular chondrocytes.
    Tan L; Yammani RR
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30674641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nuclear protein 1 knockdown inhibits proliferation and migration of HepG2 cells].
    Huang H; Zhang Y; Wang X; Zhou X; Li S; Wang M; Ren J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):782-6. PubMed ID: 26062422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased fatty acid synthase as a potential therapeutic target in multiple myeloma.
    Wang WQ; Zhao XY; Wang HY; Liang Y
    J Zhejiang Univ Sci B; 2008 Jun; 9(6):441-7. PubMed ID: 18543396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin induces myeloma cells necrosis and apoptosis and it is considered for therapeutic use.
    Wu Z; Wu L; Zou L; Wang M; Liu X
    J Chemother; 2023 Apr; 35(2):131-141. PubMed ID: 35427214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of Sprouty homolog 2 by microRNA-21 inhibits proliferation, metastasis and invasion, however promotes the apoptosis of multiple myeloma cells.
    Wang JH; Zhou WW; Cheng ST; Liu BX; Liu FR; Song JQ
    Mol Med Rep; 2015 Aug; 12(2):1810-6. PubMed ID: 25825239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rosiglitazone and all-trans retinoic acid inhibit human myeloma cell proliferation via apoptosis signaling pathway modulation].
    Huang HW; Wu DP; Chen GH; Chang HR; Chow HC; Leung AY; Liang R
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):242-6. PubMed ID: 19731824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of nuclear protein-1 induces cell cycle arrest in G0/G1 phase in glioma cells in vivo and in vitro via P27.
    Li J; Lian ZG; Xu YH; Liu RY; Wei ZQ; Li T; Lv HT; Zhao YS; Liu YJ; Dong B; Fu X
    Neoplasma; 2020 Jul; 67(4):843-850. PubMed ID: 32266819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.
    Que W; Chen J; Chuang M; Jiang D
    APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.